The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation

Cancer Causes and Control

Volumn 25, Issue 4, 2014, Pages 409-418

  Joshu, Corinne E ^a   Tsilidis, Kostantinos K ^b   Peskoe, Sarah B ^a   Giardiello, Francis M ^c,d   Dluzniewski, Paul J ^a   Nelson, William G ^d,e   Iacobuzio Donahue, Christine A ^e   Platz, Elizabeth A ^a,d,e  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF IOANNINA   (Greece)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

C reactive protein; Colorectal cancer; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CASE CONTROL STUDY; COLITIS; COLON BIOPSY; COLON MUCOSA; COLON POLYPOSIS; COLONOSCOPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOTURBIDOMETRY; INFLAMMATORY BOWEL DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; BLOOD; COLON; COLORECTAL TUMOR; INTESTINE MUCOSA; IRRITABLE COLON; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

BIOMARKERS; BIOMARKERS, TUMOR; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84896078956     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-014-0343-0     Document Type: Article

References (26)

1. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526-535 (Pubitemid 32234798)
2. Herszenyi L, Miheller P, Tulassay Z (2007) Carcinogenesis in inflammatory bowel disease. Dig Dis 25:267-269 (Pubitemid 350194181)
3. Dube C, Rostom A, Lewin G et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:365-375 (Pubitemid 351650597)
4. Rothwell PM, Wilson M, Elwin CE et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376:1741-1750
5. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA (2008) C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123:1133-1140
6. Aleksandrova K, Jenab M, Boeing H et al (2010) Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol 172:407-418
7. Prizment AE, Anderson KE, Visvanathan K, Folsom AR (2011) Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomark Prev 20:297-307
8. Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27:2217-2224
9. Heikkila K, Harris R, Lowe G et al (2009) Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 20:15-26
10. Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE (2010) C-reactive protein and the risk of cancer: a Mendelian randomization study. J Natl Cancer Inst 102:202-206
11. Chan AT, Ogino S, Giovannucci EL, Fuchs CS (2011) Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterology 140:799-808 (quiz e11)
12. World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update project. Food, nutrition, physical activity, and the prevention of colorectal cancer. AICR, Washington, DC
13. Cerilli LA, Greenson JK (2012) The differential diagnosis of colitis in endoscopic biopsy specimens: a review article. Arch Pathol Lab Med 136:854-864
14. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135
15. Wee CC, Mukamal KJ, Huang A, Davis RB, McCarthy EP, Mittleman MA (2008) Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity (Silver Spring) 16:875-880 (Pubitemid 351465646)
16. Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA (2004) Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomark Prev 13:279-284 (Pubitemid 38222561)
17. Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426-431 (Pubitemid 43268284)
18. Henriksen M, Jahnsen J, Lygren I et al (2008) C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 57:1518-1523
19. Solem CA, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11:707-712 (Pubitemid 41271173)
20. Sabatine MS, Morrow DA, Jablonski KA et al (2007) Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 115:1528-1536 (Pubitemid 46648637)
21. Rifai N, Ridker PM (2003) Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. Clin Chem 49:666-669 (Pubitemid 36379538)
22. Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807-1816
23. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125:171-180
24. World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
25. Fransson EI, Batty GD, Tabak AG et al (2010) Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II Study. J Clin Endocrinol Metab 95:5370-5374
26. Hudgins LC, Parker TS, Levine DM et al (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44:1489-1498 (Pubitemid 37279593)